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AMPA-Kainate Receptor Inhibition Promotes Neurologic
Recovery in Premature Rabbits with Intraventricular
Hemorrhage
Preeti Dohare,1Muhammad T. Zia,1,2 Ehsan Ahmed,1 Asad Ahmed,1 Vivek Yadala,1 Alexandra L. Schober,3
Juan Alberto Ortega,4 Robert Kayton,5 Zoltan Ungvari,6 Alexander A. Mongin,3 and Praveen Ballabh1,2
Departments of 1Pediatrics and 2Cell Biology and Anatomy, Regional Neonatal Center, Maria Fareri Children’s Hospital at Westchester Medical Center-New
York Medical College, Valhalla, New York 10595, 3Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208,
4Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut 06030, 5Department of Physiology and Pharmacology,
Oregon Health and Science University, Portland, Oregon 97239, and 6Reynolds Oklahoma Center on Aging, and Department of Geriatric Medicine,
University of Oklahoma Health Science Center, Oklahoma City, Oklahoma 73104
Intraventricular hemorrhage (IVH) in preterm infants leads to cerebral inflammation, reduced myelination of the white matter, and
neurological deficits. No therapeutic strategy exists against the IVH-induced white matter injury. AMPA-kainate receptor induced
excitotoxicity contributes to oligodendrocyte precursor cell (OPC) damage and hypomyelination in both neonatal and adult models of
brain injury. Here, we hypothesized that IVH damages white matter via AMPA receptor activation, and that AMPA-kainate receptor
inhibition suppresses inflammation and restores OPCmaturation,myelination, and neurologic recovery in pretermnewbornswith IVH.
We tested these hypotheses in a rabbit model of glycerol-induced IVH and evaluated the expression of AMPA receptors in autopsy
samples from human preterm infants. GluR1-GluR4 expressions were comparable between preterm humans and rabbits with and
without IVH.However, GluR1andGluR2 levelswere significantly lower in the embryonicwhitematter andgerminalmatrix relative to the
neocortex in both infants with andwithout IVH. Pharmacological blockade of AMPA-kainate receptors with systemic NBQX, or selective
AMPA receptor inhibition by intramuscular perampanel restored myelination and neurologic recovery in rabbits with IVH. NBQX
administration also reduced the population of apoptotic OPCs, levels of several cytokines (TNF, IL-, IL-6, LIF), and the density of
Iba1microglia in pups with IVH. Additionally, NBQX treatment inhibited STAT-3 phosphorylation, but not astrogliosis or transcrip-
tion factors regulating gliosis. Our data suggest that AMPA-kainate receptor inhibition alleviates OPC loss and IVH-induced inflamma-
tion and restores myelination and neurologic recovery in preterm rabbits with IVH. Therapeutic use of FDA-approved perampanel
treatment might enhance neurologic outcome in premature infants with IVH.
Key words: AMPA; myelination; NBQX; oligodendrocyte; perampanel
Significance Statement
Intraventricular hemorrhage (IVH) is a major complication of prematurity and a large number of survivors with IVH develop
cerebral palsy and cognitive deficits. Thedevelopment of IVH leads to inflammationof theperiventricularwhitematter, apoptosis
and arrested maturation of oligodendrocyte precursor cells, and hypomyelination. Here, we show that AMPA-kainate receptor
inhibitionbyNBQXsuppresses inflammation, attenuates apoptosis of oligodendrocyteprecursor cells, andpromotesmyelination
aswell as clinical recovery inpretermrabbitswith IVH. Importantly, AMPA-specific inhibitionby theFDA-approvedperampanel,
which unlikeNBQXhas a low side-effect profile, also enhancesmyelination and neurological recovery in rabbits with IVH.Hence,
the present study highlights the role of AMPA-kainate receptor in IVH-inducedwhitematter injury and identifies a novel strategy
of neuroprotection, which might improve the neurological outcome for premature infants with IVH.
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Introduction
Intraventricular hemorrhage (IVH) remains the most common
neurological complication of prematurity that results in neuro-
developmental consequences, including cerebral palsy, cognitive
deficits, and mental retardation (Ballabh, 2010). No therapeutic
or preventive strategy exists for the whitematter injury in prema-
ture infants with IVH. Because AMPA-kainate receptor activa-
tion reduces myelination in several paradigms of brain injury
(Fern and Mo¨ller, 2000; Deng et al., 2003; Follett et al., 2004;
Kanwar et al., 2004), we asked whether AMPA-kainate glutamate
receptor stimulation would induce white matter injury in survi-
vors with IVH.
IVH develops predominantly in preterm infants of 22–32 ges-
tational weeks. During this period, oligodendrocyte progenitor
cells (OPCs) are in a process of specification and maturation.
Three successive stages of oligodendrocytes have been identified,
including the late OL progenitor (preoligodendrocytes), the im-
mature OL, and the mature OL. Preoligodendrocytes (premyeli-
nating cells) are the most abundant in preterm infants of 22–32
gestational weeks, and myelinating (immature OPCs) oligoden-
drocytes are progressively increasing in number after 28–32 ges-
tational weeks (Back et al., 2001). Preoligodendrocytes are more
vulnerable to hypoxia-ischemia and glutamate receptor-
mediated toxicity compared with myelinating OPCs (Fern and
Mo¨ller, 2000; Back et al., 2002; Itoh et al., 2002; Deng et al., 2003).
These OPCs are known to express AMPA (glutamate receptors
1–4 [GluR1-GluR4]) and kainate (GluR5-GluR7 and KA1–2)
receptors (Gallo et al., 1994; Rosenberg et al., 2003). AMPA re-
ceptors are tetrameric ligand-gated ion channels located on the
postsynaptic membrane that mediate glutamatergic excitatory
transmission. The presence of GluR2 subunits renders AMPA
receptors impermeable to calcium ions (Verdoorn et al., 1991;
Geiger et al., 1995). All the GluR subtypes are expressed in OPCs;
however, their expressions vary during development and with
brain region (Fern andMo¨ller, 2000; Rosenberg et al., 2003). The
presence of GluR1, GluR3, and GluR4 subunits makes particu-
larly OPCs susceptible to excitotoxic damage during develop-
ment because Ca2 influx through these receptors triggers a
cascade of injury.
A number of studies have evaluated AMPA receptors in mod-
els of hypoxia-ischemia, cerebral trauma, and multiple sclerosis
and have reported neuroprotection with blockade of AMPA-
kainate receptors (Pulsinelli et al., 1982; Choi, 1995; Tanaka et al.,
2000; Goda et al., 2002; Groom et al., 2003). Global hypoxia-
ischemia reduces both mRNA and protein expression of
GluR2 subunit, and this reduction enhances Ca2 permeability
of AMPA receptors in neurons and glia during the insult
(Pellegrini-Giampietro et al., 1992). Moreover, glutamate accu-
mulates in perisynaptic spaces under hypoxic-ischemic condi-
tions, thereby activating AMPA receptors and eliciting glutamate
excitotoxicity. Rodent OPCs primarily express AMPA and kai-
nate receptors, but not the NMDA receptors (Gallo et al., 1994;
Rosenberg et al., 2003). Indeed, AMPA-kainate receptor antago-
nists inhibit calcium mediated excitotoxicity and cell death in
OPC culture model of oxygen-glucose deprivation (Fern and
Mo¨ller, 2000; Yoshioka et al., 2000; Deng et al., 2003). Consistent
with this, NBQX, an AMPA-kainate receptor antagonist, treat-
ment restores myelination in a neonatal rat model of hypoxia-
ischemia (Follett et al., 2004). More importantly, glutamate
excitotoxicity is thought to be amajor contributor to hypomyeli-
nation in human preterm infants (Volpe, 2009a). Despite this,
the role of glutamate excitotoxicity in IVH-induced white matter
injury and therapeutic benefits of AMPA-kainate receptor inhi-
bition in restoring myelination have remained unexplored.
Our previous studies have shown that IVH induces robust
inflammation in the periventricular white matter, leading to mi-
croglial infiltration, oxidative stress, and elevation in proinflam-
matory cytokines, TNF, IL-1, and astrogliosis (Georgiadis et
al., 2008; Chua et al., 2009; Vinukonda et al., 2010). JAK-STAT
signaling are key regulators of inflammation and cell survival.
STAT3 is expressed by both oligodendrocytes and astrocytes in
the CNS (Cattaneo et al., 1999) and is involved in the astrocytic
differentiation and astrogliosis (Herrmann et al., 2008). Based on
these considerations, we hypothesized that IVH would activate
AMPA receptors and that AMPA-kainate (NBQX) or AMPA
(perampanel) receptor inhibition might suppress inflammation
and restore OPC maturation, myelination as well as clinical re-
covery in preterm rabbit pups with IVH.We also postulated that
NBQX treatmentmight reduce astrogliosis through inhibition of
JAK-STAT signaling.
Materials andMethods
Animals. This study was performed with approval from the Institutional
Animal Care and Use Committee of New York Medical College (Val-
halla, NY).Weused a preterm rabbitmodel of glycerol-induced IVH that
has been extensively validated in our prior studies (Chua et al., 2009;
Vinukonda et al., 2010; Vose et al., 2013). Timed-pregnant New Zealand
rabbits were purchased from Charles River Laboratories. We performed
C-section to deliver the premature pups at 29 d of gestational age (full-
term  32 d). Newborn pups were reared in an infant incubator at a
temperature of 35°C. We used rabbit milk replacer (Zoologic, PetAg) to
gavage-feed the pups in a volume of2 ml every 12 h (100 ml/kg/d) for
the first 2 d, and feeds were advanced to 125,150, 200, 250, and 280ml/kg
at postnatal days 3, 5, 7, 10, and 14, respectively. We treated rabbit pups
of either sex with 50% intraperitoneal glycerol (6.5 g/kg) at 4 h of age to
induce IVH. Severity of IVH was evaluated by measuring ventricle vol-
ume (length, breadth, and depth in coronal and sagittal views) on head
ultrasound at 24 h age using an Acuson Sequoia C256 (Siemens) ultra-
sound machine. Pups with IVH were grouped as moderate (70–150
mm3) and severe (151–250mm3) IVH, based on ventricular volume (see
Fig. 1A). Ventricular volume 70 mm3 indicated either an absence of
IVH or presence of microscopic hemorrhage. Intraperitoneal glycerol
induces intraventricular hemorrhage by causing intravascular dehydra-
tion, increase in serum osmolality, consequent decline in intracranial
pressure, and rupture of fragile vessels in the ganglionic eminence (Bal-
labh et al., 2007; Georgiadis et al., 2008). The pups with moderate and
severe IVH were assigned into treatment and control group so that the
severity of IVH was balanced between the comparison groups.
NBQX and perampanel treatment. The rabbit pups with IVH were
sequentially treated with either intramuscular vehicle (saline) or NBQX
(20l, 15mg/kg) twice a day for 7 d, starting at day 1. The dose of NBQX
was calculated based on its previous use in a rodent model of hypoxia-
ischemia rats and in other models of cerebral injury (Jackson et al., 1998;
Jensen, 2005). The severity of IVH, measured by ultrasound, was similar
between the comparison groups: vehicle-treated pups with IVH and
NBQX-treated pupswith IVH. In another set of experiments, rabbit pups
with moderate to severe IVHwere sequentially treated with intramuscu-
lar perampanel (8 mg/kg) or saline once daily. The dose of perampanel
was based on its previous use in animal model and human clinical trials
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(Russo et al., 2012; Hanada et al., 2014). Rectal temperature was moni-
tored for the pups during the first 3 d using rectal probe.
Human subjects. The Research Administration of New York Medical
College (Valhalla, NY) approved the use of autopsy brain samples from
premature infants for the present study. The postmortem materials in-
cluded forebrain tissue samples harvested from premature infants with
and without IVH of 23–26 gestational weeks. These infants were of5 d
of postnatal age (Table 1), and the postmortem samples were obtained
within 18 h of their demise. We excluded premature neonates with
hypoxic-ischemic encephalopathy, meningitis, culture proven sepsis,
major brain or spinal cordmalformation, and chromosomal defects. We
included 6 preterm infants from each group (IVH and no IVH). The wall
of the cerebral hemisphere in premature infants consists of ventricular
zone, subventricular zone, intermediate zone, cortical plate, and mar-
ginal zone as illustrated by the Boulder Committee (Bystron et al., 2008).
In thismanuscript, we used the term intermediate-zone embryonicwhite
matter interchangeablywithwhitematter, ganglionic eminencewith ger-
minal matrix, and cerebral cortex with cortical plate.
Rabbit tissue collection and processing.We processed the tissues as de-
scribed previously (Ballabh et al., 2007). The brain slices were immersed
into 4% PFA in PBS (0.1 M, pH 7.4) overnight and then were cryopro-
tected by keeping them into 15% sucrose in 0.1 M PBS buffer for 24 h
followed by 30% sucrose for the next 24 h. We then froze the tissue slice
after embedding into optimum cutting temperature compound
(Sakura). Frozen coronal blocks were cut on a cryostat into coronal
sections of 20mthickness. ForWestern blot analyses, 1- to 2-mm-thick
coronal slice was harvested at the level of the midseptal nucleus and
snap-frozen on dry ice.
Human tissue collection and processing. We processed the human tis-
sues as in our previous studies (Ballabh et al., 2007). Coronal slices of 3–4
mm thickness were taken at the level of head of caudate nucleus from the
frontoparietal lobe. The coronal blocks consisted of cortical plate, em-
bryonic white matter, and ganglionic eminence. The samples were
immersion-fixed into 4% PFA in PBS for 12–18 h and were then cryo-
protected by immersing into a 15% sucrose solution in PBS, followed by
30% sucrose in PBS. The tissues were next frozen after embedding them
into optimum cutting temperature compound (Sakura). Frozen coronal
blocks were cut into sections of 20 m thickness. For Western blot anal-
yses, pieces of tissues were directly harvested from the cortex, white mat-
ter, and ganglionic eminence into Eppendorf tubes andwere snap-frozen
on dry ice.
Immunohistochemistry. Immunohistochemical staining was per-
formed as described previously (Ballabh et al., 2007). The primary anti-
bodies used in experiments included the following: rabbit GluR1 (catalog
#13185, Cell Signaling), rabbit GluR2 (catalog #ab1506, Millipore), rab-
bit GluR3 (catalog #4676, Cell Signaling), rabbit GluR4 (catalog #8070,
Cell Signaling), goat polyclonal Ki67 (catalog #275R-14, Cell Marque),
goat polyclonal Olig2 (catalog #AF-2418, R&D Systems), mouse mono-
clonal GFAP (catalog #G6171, Sigma-Aldrich), mouse monoclonal my-
elin basic protein (MBP; catalog #ab62631, Abcam), goat polyclonal
PDGFR (catalog #AR307, R&D Systems), mouse monoclonal myelin-
associated glycoprotein (MAG; catalog #AB89780, Abcam), mouse
monoclonal Stat 3 (catalog #9139, Cell Signaling Technology), rabbit
pStat3 (tyrosine 705, catalog #9145, Cell Signaling Technology), mouse
pStat3 (serine 727, catalog #9136, Cell Signaling Technology), mouse
NKX2.2 (Developmental Studies Hybridoma Bank, University of Iowa),
goat Iba1 (catalog #5076, Abcam), rabbit polyclonal NFIA (catalog
#39397, Active Motif), rabbit polyclonal Sox9 (catalog #ab5535, Milli-
pore), and sheep polyclonal Notch intracellular domain (NICD) (catalog
#AF3647, R&D Systems). Secondary antibodies used were Cy-3 conju-
gate donkey anti-mouse, Cy-3 conjugate donkey anti-goat, and FITC
conjugate donkey anti-rat (Jackson ImmunoResearch Laboratories).
Briefly, we hydrated the fixed sections in 0.1 M PBS, blocked the sections
with normal donkey serum in PBS with 0.01% Triton-X (PBST), and
incubated with the primary antibodies diluted in PBST at 4°C overnight.
After several washes in PBS, the sections were incubated with secondary
antibody diluted in 1% normal goat serum in PBS at room temperature
for 60 min. Finally, after washing in PBS, sections were mounted with
Slow Fade Light Antifade reagent (Invitrogen) andwere visualized under
a Confocal microscope (Nikon Instruments). Stereology was performed
using a fluorescentmicroscope (Axioskop2plus,Carl Zeiss)withmotorized
specimen stage for automated sampling (ASI), CCD color video camera
(Microfire, Optronics), and stereology software (Stereologer, SRC).
Fluorescent in situ detection of DNA fragmentation (TUNEL).We per-
formed TUNEL staining on fixed brain sections as described previously
(Dummula et al., 2011). For TUNEL staining, tissue sections of 12 m
thickness were air dried on slides, hydrated in 0.01 M PBS, and perme-
abilized for 5 min in 1:1 ethanol/acetic acid. An ApopTag-fluorescein in
situ DNA fragmentation detection kit (catalog #S7110, Millipore) was
used to visualize TUNEL-labeled nuclei.
Quantification of oligodendrocytes. Proliferation and maturation of
OPCs were assessed in the corona radiata and corpus callosum of pups
without IVH and pups with IVH treated with vehicle or NBQX. Cycling
OLs were identified by double-labeling the coronal sections with Olig2
and Ki67 antibodies, whereas maturation of OLs was evaluated by
double-labeling the sections with Olig2 and Nkx2.2 antibodies. All cor-
onal sections were obtained at the level of the midseptal nucleus (five 20
m sections collected at 60 m interval). Quantification was performed
by a blinded investigator in a random, unbiased fashion using a confocal
microscope with a 60 lens (Nikon Instruments). Cells were counted in
25 images (5 images  4–5 sections) for each brain region for every
parameter for each pup (n 5 pups per group).
Stereological assessment of myelin and astrocytes in the white matter.We
quantified a number of stereological parameters using computerized
software system (Stereologer, Stereology Resource Center). Briefly, 30-
m-thick coronal sections were cut on a cryostat with a section sampling
interval of 90 m to achieve 6 sections at the level of mid-septal nu-
cleus. The sections were double-labeled with MBP antibody and DAPI
(nuclear stain) and quantified as follows. The reference spaces (corona
radiata, corpus callosum) were outlined on the section 5 objective.
The volume of the outlined area (reference space) was quantified using a
point counting probe (frame 25 m 25 m; guard zone 2 m, inter-
frame interval  300 m). The total volume fraction (load) of myelin
stained by MBP antibody through a defined reference space was esti-
mated using the object area fraction probe 60 oil lens. For the area
fraction probe (frame 25 m  25 m; guard zone 2 m, interframe
interval 400 m), the user clicked on the grid points that overlapped the
myelin fibers in sections labeled with MBP. The area fraction of myeli-
nation was quantified as the ratio of product of the area per point and
number of points hitting reference area the over the product of the area
per point and number of points hitting the sampled area [a(point)
Psamp], as reported previously. A coefficient of error0.10 was consid-
ered acceptable. To assess gliosis, we quantified total volume fraction of
astrocyte cell body and glial fibers in a similar manner as for myelin
(Mouton et al., 2009).
Table 1. Characteristics of human infants with andwithout IVH
Postconceptional
age (weeks) Sex
Birth
weight (kg) IVH/no IVH Cause of death
26 Male 0.810 IVH Grade 3 Clinical sepsis
23 Male 0.57 IVH Grade 2 Clinical sepsis
23 Female 0.58 IVH Grade 3 Respiratory failure
24 Male 0.64 IVH Grade 4 Pulmonary
hemorrhage
24 Male 0.6 IVH Grade 4 Clinical sepsis
23 Female 0.52 IVH Grade 3 Respiratory failure
23 Female 0.53 No IVH Respiratory failure
25 Female 0.71 No IVH Metabolic acidosis,
respiratory failure
23 Male 0. 45 No IVH RDS, respiratory
failure
24 Male 0.61 No IVH Clinical sepsis
25 Male 0.73 No IVH Metabolic acidosis,
respiratory failure
24 Female 0.56 No IVH Respiratory failure
RDS, Respiratory distress syndrome.
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Western blot analyses. We homogenized the frozen brain tissue in a
sample buffer (3% SDS, 10% glycerol, and 62.5 mM Tris-HCl) using a
mechanical homogenizer and then sonicated the lysate before centrifu-
gation. Supernatant protein concentration was measured using a BCA
protein assay kit (Pierce, kit #23227, Thermo Scientific), and dilutions of
BSA were used to create a standard curve. After boiling the samples in
Laemmli buffer (catalog #161-0737, Bio-Rad), total protein samples
were separated by SDS-PAGE (Vinukonda et al., 2010). Equal amounts
of protein (10–20 g) were loaded onto 4%–15% or 4%–20% gradient
precast gels (Bio-Rad), based on the molecular weight of the target pro-
tein. Separated proteins were transferred onto PVDF membrane by
electro-transfer. Membranes were then incubated overnight with pri-
mary antibodies. We detected target proteins with chemiluminescence
ECL system (GE Healthcare) by using secondary antibodies conjugated
with HRP (Jackson ImmunoResearch Laboratories). We stripped the
membrane using stripping buffer (2.5% SDS, 0.7% 2-mercaptoethanol,
62.5 mM Tris-HCl, pH 6.8) and then incubated with -actin antibody
(catalog #A5316, Sigma) followed by secondary antibody and detection
with chemiluminescence ECL system. As described previously (Vinu-
konda et al., 2010), the blots from each experiment were densitometri-
cally analyzed using ImageJ, and optical density (OD) values for each
protein of interest were normalized to those of -actin. Antibodies used
for Western blot analyses were the same as for immunohistochemistry.
Calcium signaling studies.OPCswere isolated fromE29 rabbit brain, as
described previously (Ortega et al., 2013). Briefly, whole forebrain tissue
was harvested from an anesthetized rabbit pup. The brain was mechan-
ically dissociated in 0.025% trypsin-EDTA solution. OPCs were then
isolated from the homogeneous cell suspension using anti-O4 mi-
crobeads (Magnetic Activated Cell Sorting protocol, Miltenyi Biotec),
and 100,000–150,000 cells per coverslip were plated. The OPCs were
cultured for 3 d in expansionmedium at 37°C. The cells were loadedwith
Fluorforte (ENZ-51017, Enzo Life Sciences) for 60 min at room temper-
ature per the manufacturer’s instructions. To assess AMPA-kainate-
mediated Ca2 uptake, cells were incubated with NBQX (20 M) or
vehicle and then were treated with plasma. After 40 min of incubation,
the images were acquired at identical settings using Nikon confocal mi-
croscope, and fluorescence intensity was calculated using NIS software
(Nikon).
qRT-PCR. Gene expression was quantified by real-time PCR, as de-
scribed previously (Ballabh et al., 2007). Briefly, total RNA was isolated
using a RNeasyMini kit (catalog #74104, QIAGEN) from a coronal brain
slice taken at the level of the mid-septal nucleus. cDNA was synthesized
using Superscript II RT enzyme (catalog #05081955001, Roche) followed
by a real-time quantitation using an ABI Prism 7900HT detection sys-
tem. TaqMan probes were bought from Invitrogen. Their assay IDs were as
follows: GAPDH (Oc03823402_g1), GRIA1 (Hs00990746_m1), GRIA2
(Hs00968358_m1), GRIA3 (Hs01557466_m1), GRIA4 (Hs00898778_m1),
TNF (Oc03397716_g1), IL1 (Oc03823250_s1), CNTF (Oc0339
7817_m1), LIF (Hs01055668_m1), IL-6 (Oc04097053_m1), and interfer-
on- (Oc04096817_m1).
Electron microscopy. We processed brains (14 d) from the glycerol
treated rabbit pups without IVH, pups with IVH, and the NBQX-treated
pups with IVH (n  3 or 4 each). We took coronal slices (2 mm thick-
ness) from freshly harvested rabbit pup brain using a brain slicer matrix
and then dissected corona radiata and corpus callosum in a Petri dish
under a SteReo discovery microscope (Carl Zeiss). The tissue samples
from the white matter were fixed into 2.5% glutaraldehyde overnight.
The tissue samples were then washed in 0.1 M sodium cacodylate buffer,
pH 7.4, postfixed in buffered osmium tetroxide for 1–2 h, stained en bloc
with 1%uranyl acetate, dehydrated in graded ethanol solutions, and then
embedded in epoxy resin. We placed sections of 60–90 nm thicknesses
onto 200 mesh grids, stained with uranyl acetate and lead citrate, and
then examined with a Techni 12 electron microscope at 80 kV. For each
brain, we acquired 12–20 digital images using a 16 megapixel camera
(Advanced Microscopy Techniques). Electron micrographs were as-
sessed formyelinated axons per unit area; and the g-ratio (ratio of axonal
diameter with myelin sheath to the axonal diameter without myelin
sheath) of myelinated axons were computed in the three groups of pups
using ImageJ (National Institutes of Health).
HPLC analysis of amino acid content in CSF samples. The CSF samples
were snap-frozen on dry ice and stored at80°C until the day of HPLC
assay. Samples were thawed on ice and immediately deproteinated using
ice-cold methanol (1:4). After 15 min incubation on ice, samples were
clarified by centrifugation (15,000  g for 15 min). The supernatants
were removed and analyzed for amino acid content using a 1200 HPLC
setup with fluorescence detector (Agilent Technologies) as previously
described (Dohare et al., 2014). Briefly, the amino acid levels were quan-
tified after derivatization with o-phthalaldehyde in the presence of
-mercaptoethanol. The derivatives were separated on an Eclipse
XDB-C18HPLC column, and fluorescence intensities of separated prod-
ucts were compared with the calibration standards of L-glutamate,
L-glutamine, taurine and L-alanine.
Statistics and analysis.Data are presented asmean SEM.To compare
the levels of MBP, MAG, CNPase, and cytokines as well as cell counts
between three groups (no IVH, vehicle, and NBQX or perampanel-
treated pups), we used one-way ANOVA. To assess the difference in the
protein andmRNA expression of glutamate receptors between pups with
and without IVH at 24 and 72 h age, we used two-way ANOVA with
repeated measures. Likewise, protein expression of GluR1-GluR4 in the
three brain regions (cortex, white matter, and germinal matrix) in pre-
term infants with and without IVH was compared using two-way
ANOVA with repeated measures. The repeated factor was applied to the
three brain regions: ganglionic eminence, white matter, and cortex. All
post hoc comparisons between means were done by Tukey multiple-
comparison test at 0.05 significance.
Results
IVH does not affect glutamate receptor expression in rabbits
and humans
To determine whether IVH affects the expression of AMPA re-
ceptor subunits, GluR1-GluR4, in premature human infants
(postmortem) of 23–26 weeks gestational age, we labeled coronal
sections from the forebrain with GluR1-GluR4 specific antibod-
ies. GluR1-GluR4 were abundantly expressed in the neocortical
mantle (cortex), embryonic whitematter, and germinalmatrix of
preterm infants (data not shown). GluR1 was expressed on a
number of O4 OPCs in the white matter and germinal matrix,
however weakly onGFAP radial glia of the germinalmatrix and
astrocytes of the white matter. GluR2 reactivity was observed on
both O4 OPCs and GFAP astrocytes as well as on radial glia.
GluR3 and GluR4 were abundantly expressed on GFAP astro-
cytes and on a few O4 oligodendrocytes. The expression of
GluR1-GluR4 was weak to absent on MAP2 neuronal progen-
itors in the germinal matrix; however, they were abundantly ex-
pressed on the cortical neurons. Overall, immunoreactivity of
GluR1-GluR4 in the cortex, white matter, and germinal matrix
was comparable between preterm infants with and without IVH.
However, comparison between the brain regions revealed that
GluR1-GluR2 immunoreactivity was relatively lower in the white
matter and germinal matrix compared with the cortex. Western
blot analyses confirmed that GluR1-GluR4 levels were similar
between infants with and without IVH in the three brain regions
(Fig. 1C). However, GluR1 and GluR2 were reduced in the white
matter and germinal matrix compared with the cortex in both
infants with IVH and without IVH (p 0.001, all).
We next evaluated the protein expression of GluR1-GluR4 in
the forebrain of preterm rabbits (E29) with IVH versus without
IVH at 48 and 72 h postnatal age by Western blot analyses (Fig.
2A). There was no significant difference in the levels of these
receptors between pups with and without IVH. Accordingly,
mRNA expression of GluR1-GluR4 was comparable in the fore-
brain of preterm rabbits with and without IVH at both postnatal
day 3 (D3) and day 7 (D7) (Fig. 2B). There was no significant
interval change in the expression of these receptors. Together, the
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development of IVH did not affect GluR1-GluR4 expression in
rabbit pups or human infants with and without IVH. However,
both GluR1 and GluR2 were reduced in the periventricular ger-
minalmatrix and embryonicwhitematter relative to the cortex of
premature infants. A reduction in GluR2 might render these
brain regions more vulnerable to glutamate-induced toxicity.
Glutamate levels in the CSF showed a trend toward increase
in rabbits with IVH
Glutamate has a pivotal role in neurological disorders, and its
levels are increased in cerebral ischemia, trauma, and degenera-
tions (Da´valos et al., 1997). Therefore, we postulated that gluta-
mate might be increased in the pups with IVH. The cerebral
ventricles are filled with blood in these pups with IVH, and it is
gradually absorbed by days 3–5. To avoid blood contamination in
the samples and based on the feasibility in premature pups, we
assayed glutamate in CSF obtained from cisterna magna punc-
ture at D3 and D7. The glutamate levels were measured by high-
performance chromatography in the CSF of (1) rabbits without
IVH (no glycerol), (2) glycerol-treated rabbits without IVH, and
(3) glycerol-treated rabbits with IVH. The mean levels of CSF
glutamate in pups with IVH was twofold to threefold higher com-
paredwith pupswithout IVH (no glycerol) and approximately two-
fold higher relative to glycerol-treated pups without IVH (Fig. 2C).
However, these comparisons were not statistically significant. The
CSF levels of two major extracellular amino acids (glutamine and
alanine) were similar between the three sets of pups (data not
shown), suggesting specificityofobservedchanges inCSFglutamate.
Some elevation in CSF glutamate levels in glycerol-treated pups
without IVH (relative to pups without glycerol treatment) can be
attributed to a failure of head ultrasound to detect microscopic
bleeds. Indeed,microscopic IVHafter glycerol treatment canpoten-
tially induce some increase inCSF glutamate levels. Together, gluta-
mate levels showed an insignificant trend toward increase in pups
with IVH, which is consistent with the studies in rat models of
hypoxia-ischemia (Vannucci et al., 1999).
NBQX treatment restores myelination in rabbit pups
with IVH
Because AMPA-kainate activation mediates oligodendrocyte
death and inhibits maturation of OPCs as well as myelination in
models of hypoxia-ischemia (Follett et al., 2000, 2004; Volpe,
Figure 1. IVH in rabbit brains and AMPA receptor subunits in premature human infants. A, Coronal brain slice taken from frontal lobe of E29 rabbit pup, which shows normal slit-like ventricle
(arrowhead), moderate hemorrhage in the ventricle (middle panel), and severe hemorrhage resulting in fusion of the two ventricles (block arrows). Scale bar, 1 cm.B, Coronal and sagittal views of
head ultrasound of rabbits with (bottom) and without IVH (top). Arrow indicates slit-like ventricle in pups without IVH. Arrowhead indicates large IVH. C, Western blot analysis for AMPA receptor
subunits GluR1-GluR4 in the brain tissue from preterm human infants with andwithout IVH. Data aremean SEM (n 5, each group). Protein expression values were normalized to the levels of
-actin. Therewasno significant difference in the expression of anyGluRs between infantswith IVHandwithout IVH. There are significantly reduced levels of GluR1 andGluR2 in thegerminalmatrix
and white matter relative to the cortex in both infants with and without IVH. ***p 0.001, cortex versus germinal matrix or white matter in infants without IVH. ###p 0.001, cortex versus
germinal matrix or white matter in infants with IVH.
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2009b), we evaluated the effect of AMPA-kainate receptor inhi-
bition on myelination in rabbits with IVH. To this end, we com-
pared myelination among three groups of pups at D14: (1)
glycerol-treated pups without IVH, (2) vehicle-treated pups with
IVH, and (3)NBQX-treated pups with IVH. To clarify, intraperi-
toneal glycerol was used to induce IVH, and intramuscular vehi-
cle was administered for comparison with intramuscular NBQX.
Severity of IVH was comparable between vehicle- and NBQX-
treated groups, as measured by head ultrasound. Stereological
quantification of MBP in immunostained sections revealed that
the volume fractions (myelin load) of MBP in the corpus callo-
sum and corona radiata were significantly less in pups with IVH
relative to controls without IVH (p 0.004) and that intramus-
cular NBQX enhanced the expression of MBP (p  0.031; Fig.
3A). Consistent with stereological analyses,Western blot analyses
demonstrated that MBP, MAG, and CNPase levels were reduced
in pups with IVH compared with controls without IVH (p 
0.01, p  0.01, and p  0.001, respectively) and that NBQX
treatment significantly increased MBP, MAG, and CNPase ex-
pression in pups with IVH (p 0.001, p 0.011, and p 0.001,
respectively; Fig. 3B,C).
Ultrastructural evaluation of the corpus callosum and corona
radiata demonstrated that numbers of myelinated axons were
fewer in pups with IVH compared with controls without IVH
(p  0.05; Fig. 3E) and that NBQX treatment significantly in-
creased the density of myelinated axons in pups with IVH (p 
0.05). Moreover, the g-ratio was comparable in the three groups
of pups (0.71  0.008 vs 0.73  0.016 vs 0.71  0.01, in pups
without IVH, IVH with vehicle, and NBQX treatment, respec-
tively). This suggests that AMPA-kainate inhibition restores my-
elination and the morphology of the myelin sheath in the white
matter of preterm rabbit pups with IVH.
NBQX administration restores neurological recovery
To determine whether NBQX treatment enhances neurological
recovery of preterm rabbits with IVH, we performed neurobe-
havioral assessments of three sets of preterm pups at D14 (Table
2), as previously described (Vinukonda et al., 2010; Vose et al.,
2013). Vehicle- and NBQX-treated groups were balanced with
respect to the severity of IVH. All glycerol-treated pups without
IVH were neurologically normal. In contrast, we found symmet-
ric quadriparesis in 2 pups (18%), asymmetric quadriparesis
(left	 right sidedweakness) in one, and left legweakness (mono-
paresis) in one in the vehicle-treated group. The pups with
quadriparesis were completely unable to walk, and pups with
monoparesismanifestedwith clumsiness in the gait. Amongpups
Figure 2. IVH does not affect glutamate receptor expression in preterm rabbits. A, Representative Western blot analysis of the AMPA receptor subunits GluR1-GluR4 in the brain tissue from
preterm rabbits with andwithout IVH at postnatal age 48 and 72 h. Adult rat brain was used as positive control. Data aremean SEM (n 5 each). Values were normalized to-actin. There was
no significant difference in the expression of GluRs between pups with IVH and without IVH. B, Data are mean SEM (n 5 each group). Bar charts represent mRNA expression of GluR1-GluR4
(GRIA 1–4). ThemRNAexpression for these receptorswas comparable between pupswith andwithout IVH at both D3 andD7. C, CSF glutamate levels showa trend toward increase in pupswith IVH
relative to controls; however, there was no significant difference in CSF glutamate levels between pups with and without IVH at D3 and D7. Glyc, Glycerol.
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treated with NBQX, one pup (10%) showed quadriparesis and
the remaining pups were neurologically normal. The scores for
gait were significantly higher in NBQX-treated pups than in ve-
hicle controls (p 0.05). The average distance walked in 60 s was
farther in NBQX-treated pups compared with vehicle controls
(p  0.04). The percentage of pups showing the ability to hold
their position on a ramp pitched at 60° inclination for20 s was
more inNBQX-treated pups comparedwith saline controls (90%
vs 64%). Scores for the righting reflex, forearm, and hind arm
movement were significantly better in NBQX-treated pups com-
pared with vehicle controls (p  0.05, for all). There was no
difference in sensory and cranial nerve assessment of the three
sets of rabbit pups. Importantly, we did not observe any apparent
adverse effect attributable to NBQX treatment among pups with
IVH receiving this medication. To test whether NBQX induces
hypothermia, rectal temperature was monitored in these three
sets of pups during the first 3 d, who were reared in an infant
incubator. There was no significant difference in the temperature
between groups, which ranged from 36°C to 37°C.
NBQX treatment reduces Ca signaling, apoptosis, and
enhances maturation of OPC
Oxygen-glucosedeprivation (simulatingbrain ischemia)ofOPCs in
culture model activates Ca2-permeable AMPA-kainate receptors
(Denget al., 2003).Becauseplasmahashighglutamate levels andcan
damage OPCs due to the presence of thrombin and other compo-
nents (Juliet et al., 2009), we postulated that treating OPC with
plasma (simulating IVH) might enhance calcium influx in O4
OPCs. To this end, we isolated pure population of O4 cells from
the corona radiata and corpus callosum of E29 rabbits using Mag-
netic Activated Cell Sorting technology. We evaluated changes in
Ca2 content using membrane-permeable Ca2-sensitive fluores-
cent dye, FluoForte. Treatment of OPC with plasma significantly
increased FluoForte signal intensity (p 0.01), andAMPAreceptor
Figure3. NBQX treatment restoresmyelination in rabbitswith IVH.A, Representative immunofluorescent imagesofMBP in the corona radiata and corpus callosumofD14pups.Data aremean
SEM (n 8 each group). Volume fractions of MBP were higher in the corpus callosum and corona radiata of NBQX-treated pups compared with vehicle controls with IVH. Scale bar, 200m. V,
Ventricular side.B, Typical Western blots for MBP expression in the forebrain of premature rabbit pups, as indicated, at D14. Adult rat brain was used as positive control. Each lane represents lysate
from awhole coronal slice taken at the level of midseptal nucleus of one brain. Bar chart representsmean SEM (n 5, each group). MBP expressionwas higher in NBQX-treated pups compared
with the vehicle controls. C, RepresentativeWestern blot analysis for MAG expression in the forebrain of pups as indicated at D14. Adult rat brain was used as positive control. Bar graph represents
mean SEM (n 8 each group). MAG expression was higher in NBQX-treated pups compared with vehicle controls. D, Western blot analysis for CNPase expression in the forebrain of pups as
indicated at D14. Bar graph representsmean SEM (n 5, each group). Similar toMBP andMAG, CNPase expressionwas higher in NBQX-treated pups comparedwith vehicle-treated controls. E,
Representative electron micrograph from rabbit pups with and without IVH, and pups with IVH treated with NBQX at D14. Myelinated axons were fewer in pups with IVH compared with controls
without IVH, andNBQX treatment significantly increased the number ofmyelinated axons in pupswith IVH. *p 0.05, **p 0.01, ***p 0.001, pupswith versuswithout IVH. #p 0.05, ##p
0.01, vehicle versus NBQX-treated pups with IVH. ###p 0.001, vehicle versus NBQX-treated pups with IVH. Scale bar, 1m. Glyc, Glycerol.
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inhibitionbyNBQX treatment reduced the fluorescence intensity in
the OPCs (p 0.05; Fig. 4A). This could be amechanism by which
IVHmay increaseCa2 influx into theOPCs todamage thesecells in
our rabbit model.
Wenext askedwhetherNBQX treatment reduced apoptosis of
OPCs in rabbits with IVH. To this end, we double-labeled brain
sections for TUNEL and O4 antigen. We found that apoptotic
O4 cells were significantly more abundant in the corpus callo-
sum and corona radiata of pups with IVH compared with
glycerol-treated controls without IVH at D3 (p 0.01) and that
NBQX treatment substantially reduced the density of apoptotic
O4 cells (p 0.004; Fig. 4B).
Because NBQX enhanced myelination in our glycerol model
of IVH, we postulated that NBQX treatment might affect prolif-
eration and maturation of OPCs. To assess proliferation of OPC
in the corona radiata and corpus callosum, we compared cycling
and total PDGFR progenitor cell in glycerol-treated pups
without IVH, vehicle-treated, andNBQX-treated pupswith IVH.
The densities of both total and cycling PDGFR cells showed a
trend toward reduction in pups with IVH compared with con-
trols without IVH. However, the comparisons between the three
groups were not statistically significant (Fig. 4C).
We next evaluated the effect of NBQX treatment onOPCmatu-
ration in sections double-labeled with Olig2- and Nkx2.2-specific
antibodies. We found that Olig2OPCs were comparable between
the three groups. However, the population of Olig2Nkx2.2 cells
was significantly reduced in pupswith IVHrelative to controlswith-
out IVH (p 0.006), and NBQX treatment significantly increased
their density (p 0.04) in the corona radiata and corpus callosum
(Fig. 4D). This suggests that NBQX treatment restores the matura-
tion of OPCs in pups with IVH. Consistent with this conclusion,
we found higher levels of CNPase (2
,3
-cyclic nucleotide-3
-
phosphodiesterase), as measured by Western blot analyses, in
NBQX-treated pups with IVH compared with vehicle controls (Fig.
3D) at D14. Together, NBQX treatment favorsmaturation of OPCs
but does not affect its proliferation.
NBQX suppresses microglia infiltration and
proinflammatory cytokines
As glutamate excitotoxicity might activate microglia and cerebral
inflammation (Volpe, 2009b; Kostic et al., 2013), we asked whether
IVH-induced cerebral inflammation and production of inflamma-
tory mediators, and whether this can be alleviated by NBQX treat-
ment.To this end,wequantified Iba1microglia in immunolabeled
sections and assayed mRNA expression of proinflammatory cyto-
kines, including TNF, IL1, IL-6, LIF, CNTF, and interferon-, by
qRT-PCR using TaqMAN probes (Fig. 5).
We found that the development of IVH significantly increased
the density of Iba1microglia in both periventricular ganglionic
eminence and corona radiata (p 0.001 and p 0.004, respec-
tively) and, more importantly, NBQX treatment restored their
density (p  0.001, p  0.05; Fig. 5A,B). Consistent with these
findings, the onset of IVH led to an elevation in the expression of
TNF, IL1, IL-6, and LIF mRNA (p  0.004, p  0.001, p 
0.001, and p 0.001, respectively) andNBQX treatment reduced
their levels (p  0.005, p  0.035, p  0.001, and p  0.013,
respectively; Fig. 5C). However, the levels of interferon- and
CNTF were neither elevated in pups with IVH nor reduced with
NBQX treatment. This suggests that IVH-induced inflammation
is significantly curtailed by NBQX treatment.
NBQX treatment does not affect astrogliosis
Because AMPA receptor inhibition alleviates Ca2-mediated exci-
totoxicity and cell death (Fern andMo¨ller, 2000; Follett et al., 2004),
we reasoned thatNBQXtreatmentmight reduceastrogliosis.Hence,
we used stereological evaluation of immunostained sections and
Westernblot analyses to compareGFAPexpressionbetweencontrol
pups without IVH (glycerol treated), vehicle- and NBQX-treated
pups with IVH. We found that GFAP expression was elevated
inpupswith IVHcomparedwith controlswithout IVHatD14 (p
0.013 and p 0.001 in stereology andWestern blot analyses, respec-
tively; Fig. 6A–C). However, there was no difference in the GFAP
expression between vehicle- and NBQX-treated pups with IVH.
GFAP expression was also elevated at D3 in pups with IVH com-
pared with controls without IVH (p 0.01).
Because NBQX treatment promotes myelination in pups
with IVH, we reasoned that this might influence myelination
or gliosis in healthy pups. Hence, we compared MBP and
GFAP levels in the vehicle- and NBQX-treated healthy pups at
D14 (data not shown). We found that NBQX treatment did
not significantly affect myelination or astrogliosis in healthy
pups without IVH.
NBQX blocks p-STAT3 signaling but does not affect
astrocyte proliferation
STAT-3 is a member of JAK-STAT signaling family, which trig-
gers responses of several cytokines and growth factors (Aaronson
and Horvath, 2002). Elevation in both total and p-STAT3 indi-
cates activation of STAT-3 signaling (Sehgal, 2008). Because ele-
Table 2. Neurobehavioral evaluation of NBQX- and vehicle-treated pups with IVH
and controls without IVH at the postnatal day 14a
System Test
No IVH
(n 11)
IVH vehicle
(n 11)
IVH, NBQX
(n 10)
Cranial nerve Aversive response to alcohol 3 (3, 3) 3 (3, 3) 3 (3, 3)
Sucking and swallowing 3 (3, 3) 3 (3, 3) 3 (3, 3)
Motor Motor activity
Head 3 (3, 3) 3 (3, 3) 3 (3, 3)
Fore legs 3 (3, 3) 3 (1.25, 3)# 3 (3, 3)*
Hind legs 3 (3, 3) 3 (1, 3)# 3 (3, 3)*
Righting reflexb 5 (5, 5) 4 (0.5, 5)# 5 (5, 5)*
Locomotion on 30° inclinationc 3 (3, 3) 3 (1, 3)# 3 (3, 3)*
Toned: forelimb 0 (0, 0) 0 (0, 0) 0 (0, 0)
Toned: hindlimb 0 (0, 0) 0 (0, 0) 0 (0, 0)
Inability to hold their position
at 60°
0% 36% 10%
Inclination for20 s (latency to
slip down the slope, if15 s)
Inability to walk	60 inches
in 1 min (%)
0% 36% 10%
Gaite 4 (4, 4) 3 (1.5, 4)# 4 (3.5, 4)*
Motor impairmentf 0% 36% 10%
Sensory Facial touch 3 (3, 3) 3 (3, 3) 3 (3, 3)
Pain 3 (3, 3) 3 (3, 3) 3 (3, 3)
aValues are median (interquartile range). Zero is the worst response and 3 is the best response, unless otherwise
noted.
bScore (range, 1–5): no. of times turns prone within 2 s when placed in supine out of 5 tries.
cScore (range, 0–3): 0, does notwalk; 1, takes a few steps (8 inches); 2, walks for 9–18 inches; 3, walks verywell
beyond 18 inches.
dScore (range, 1–3): 0, no increase in tone; 1, slight increase in tone; 2, considerable increase in tone; 3, limb rigid in
flexion or extension.
eGait was graded as follows: 0, no locomotion; 1, crawls with trunk touching the ground for few steps and then rolls
over; 2,walks taking alternate steps, trunk low, and cannotwalk on inclined surface; 3,walks taking alternate steps,
cannotpropel its bodyusing synchronously thehind legs, butwalkson30° inclined surface; 4,walks, runs, and jumps
without restriction, propels the body using synchronously the back legs, but limitation in speed, balance, and
coordination manifesting as clumsiness in gait; 5, normal walking.
fMotor impairmentwas defined asweakness in either fore legs or hind legs and distancewalked60 inches in 60 s.
*p 0.05, for vehicle-treated versus NBQX-treated pups with IVH.
#p 0.05, for glycerol-treated pups without IVH and vehicle-treated pups with IVH.
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vated levels of several proinflammatory cytokines in pups with
IVH were substantially reduced by NBQX treatment, we postu-
lated that the IVH might induce STAT3 phosphorylation and
that NBQX treatment could suppress the STAT3 activation. To
this end, we compared levels of STAT and p-STAT (tyrosine 705
and serine 707) in control pups without IVH, vehicle-, and
NBQX-treated pups with IVH at D3. We found that IVH en-
hanced total STAT (p  0.05) and phosphorylation of tyrosine
residues in STAT3 species (p  0.001), but not of serine. More
importantly, NBQX treatment reduced phosphorylation of ty-
rosine (tyrosine 705) in STAT3 protein in pups with IVH (p 
0.001; Fig. 7A). Elevation in both total and p-STAT3 indicates
their activation (Sehgal, 2008). To determine the specific neural
cell type undergoing STAT-3 phosphorylation, we double-
labeled the brain sections with p-STAT3 and Olig2, GFAP, or
Sox2 antibodies. We found that p-STAT-3 cells were more
abundant in rabbits with IVH compared with controls without
IVH and NBQX-treated pups (Fig. 7B). Importantly, p-STAT-3
was abundantly expressed on Sox2 cells of the ventricular zone
and subventricular zone and also on several Olig-2, GFAP,
and S100 cells of the periventricular whitematter of pups with
IVH (Fig. 7B). This suggests that STAT-3 phosphorylation in-
volves Sox2 progenitors and also cells of both astrocytic and
oligodendroglial lineage.
JAK-STAT pathway is activated in brain disorders, including
ischemia, degeneration, and cancer, and regulates expression of
genes related to cell survival, proliferation, and differentiation
(Cattaneo et al., 1999). STAT signaling also plays key role in
astrogliosis (Herrmann et al., 2008). Because IVH increased
GFAP expression and as NBQX inhibited STAT3 activation, we
postulated that NBQX treatment might attenuate astrocyte pro-
liferation and affect transcription factor regulating astrocytes, in-
cluding NFIA and Sox9. To this end, we (1) evaluated astrocyte
proliferation by double immunolabeling sectionwith S-100 and
ki67 antibodies and (2) quantified expression of NFIA and Sox9
transcription factor at D3. We found that NBQX treatment nei-
ther affected proliferation of S100  astrocytes (data not
shown) nor significantly influenced protein ormRNA expression
ofNFIA and Sox9 expression (Fig. 7B; qRT-PCRdata not shown).
Moreover, NICD protein and Hes1 mRNA expression were not
Figure 4. NBQX treatment reduces Ca 2 influx in O4 cells treated with plasma andminimizes apoptosis and promotes maturation of OPC in rabbits with IVH. A, Representative image of the
Fluo-Forte-labeled O4 cells exposed to plasma or plasmawith NBQX. Quantification of mean fluorescence intensities is represented as mean SEM (n 5). B, Representative images of TUNEL
(green) and O4 immunostaining for OPCs (red) in the corona radiata, as indicated. Insets, High-magnification views. TUNEL OPCs were reduced in NBQX-treated pups with IVH compared with
vehicle controls. C, A typical image of cryosections (D3 pup) double-labeled with PDGFR- and Ki67-specific antibodies. Graphs represent mean SEM (n 5 each). Total (both cycle and
noncycling)PDGFR cells are comparable in the threegroups, as indicated. CyclingPDGFR cells are reduced inpupswith IVH, andNBQX treatment showsan insignificant trend toward increase
in the density of these cells comparedwith vehicle controls.D, Representative images of cryosections of D7 pup double-labeledwith Olig2- andNkx2.2-specific antibodies. Quantification represents
mean SEM (n 5 each). Note an increase in Nkx2.2Olig2 cells in NBQX-treated pups relative to vehicle controls. *p 0.05, pups with versus without IVH. **p 0.001, pups with versus
without IVH. #p 0.05, vehicle versus NBQX-treated pups with IVH. ##p 0.001, vehicle versus NBQX-treated pups with IVH. Scale bar, 50m.
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substantially affected by the development of IVH and subsequent
NBQX treatment (Fig. 7B; data not shown), indicating a lack of
effect of NBQX on Notch signaling pathways. Together, IVH
activates STAT-3 phosphorylation, which is abrogated by NBQX
treatment. A failure of NBQX treatment to affect astrocyte pro-
liferation and astrogliosis suggests that pathways other than
STAT-3 activation, such as bone morphogenetic protein and
transforming growth factor , might be playing an important
role in the IVH-induced gliosis.
Effect of FDA-approved perampanel onmyelination, gliosis,
and neurobehavior
NBQX is known to offer neuroprotection in numerous animal
models of brain injury (Pulsinelli et al., 1982; Choi, 1995; Goda et
al., 2002; Groom et al., 2003), but it has not been approved for
clinical use in patients because of its adverse effects. By contrast,
perampanel is a noncompetitive inhibitor of AMPA receptors
and has been approved by FDA for use as an antiepileptic in
patients with partial-onset seizures. Because perampanel is a safe
and specific AMPA inhibitor and can potentially be used in in-
fants with IVH, we evaluated the effect of intramuscular peram-
panel treatment in pups with IVH starting at D1. To this end, we
compared myelination and astrogliosis in pups without IVH,
perampanel-treated pups with IVH, and vehicle controls. Stereo-
logical quantification of MBP in immunolabeled sections re-
vealed that the volume fractions of MBP in the corpus callosum
and corona radiata were significantly higher in perampanel-
treated pups with IVH compared with vehicle controls (p 
0.004; Fig. 8A). Accordingly,Western blot analyses demonstrated
thatMBP andMAG levels were reduced in pupswith IVH relative
to controls without IVH (p  0.001 each) and that perampanel
treatment significantly increased MBP and MAG levels in pups
with IVH (p 0.001 each; Fig. 8B,C).
WenextevaluatedGFAPexpression in theabovesetsofpups.We
found that GFAP expression was higher in IVH pups relative to
controlswithout IVHbothon stereological quantificationof immu-
nostained sections and Western blot analyses (p  0.006 and p 
0.01, respectively), and perampanel treatment did not affect the
GFAP expression in pups with IVH. Likewise, the development of
IVH elevated vimentin expression on Western blot analyses (p 
0.001), and perampanel treatment did not affect its levels.
We next compared neurobehavioral performance of per-
ampanel- and saline-treated pups with IVH (n  8 each). The
two groups were comparable with respect to the severity of IVH.
All glycerol-treated pups without IVH were neurologically nor-
mal. In contrast, we found symmetric quadriparesis in one pup
Figure 5. NBQX suppresses microglia infiltration and production of proinflammatory cytokines. A, Representative images of cryosections form the corona radiata stained with Iba-1-specific
antibody and sytox (nuclear stain) of D3 pups. Insets, High-magnification views of the boxed area in the image. Iba-1microglia (arrow) are more abundant in pups with IVH relative to controls
without IVH, andNBQX treatment reduces their density. Scale bar, 50m.B, Data aremean SEM (n5 eachgroup), showingdata fromcorona radiata andgerminalmatrix (GM).C, TNF, IL1,
IL-6, and LIFmRNA levels were elevated in pups with IVH compared with controls without IVH at D3, and NBQX treatment reduced these levels in pups with IVH. Interferon (IFN) and CNTF gene
expressionwas similar between groups. Data aremean SEM (n 5 each group). *p 0.05, pupswith versus without IVH. **p 0.01, pupswith versus without IVH. ***p 0.001, pupswith
versus without IVH. #p 0.05, vehicle versus NBQX-treated pups with IVH. ##p 0.01, vehicle versus NBQX-treated pups with IVH. ###p 0.001, vehicle versus NBQX-treated pups with IVH.
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(12.5%), and left/right leg weakness (monoparesis, 25%) in
two saline-treated pups. The pup with quadriparesis was com-
pletely unable to walk, and pups with monoparesis manifested
with clumsy gait. All perampanel-treated pups were neurologi-
cally normal. The scores for gait were significantly higher in
perampanel-treated pups compared with saline controls (p 
0.05). The percentage of pups showing inability to hold their
position on a ramp pitched at 60° inclination for 20 s was
significantly higher in NBQX-treated pups compared with the
saline controls. Scores for the righting reflex and hind armmove-
ment were superior in perampanel-treated pups compared with
saline controls (p 0.05, all). There was no significant difference
in sensory and cranial nerve assessment of the three sets of rabbit
pups. Importantly, we did not observe any apparent adverse ef-
fect attributable to perampanel treatment among pups with IVH.
There was also no significant difference in the temperature be-
tween groups, similar to NBQX-treated pups.
Discussion
IVH occurs in 12,000 premature infants every year in the
United States. Because survival rates of premature infants have
strikingly improved, neurologic sequelae of IVHhave emerged as
important public health concerns. Yet, no effective therapy exists
to prevent the white matter injury in the survivors of IVH. In the
present study, we found that AMPA-kainate receptor inhibition
alleviated IVH-induced inflammation, reduced calcium signal-
ing in OPCs, restoredmaturation of OPCs, and promotedmyeli-
nation and neurologic recovery in preterm rabbits with IVH.
Similar restoration of myelination and neurological function
were observed with the AMPA-kainate antagonist NBQX and the
FDA-approvedAMPA-specific inhibitor perampanel. Hence, the
present study highlights the role of AMPA-kainate receptor in
IVH-induced white matter injury and identifies a novel strategy
of neuroprotection in premature newborns with IVH.
The most important and novel observation in this study was
that AMPA-kainate receptor inhibition reduced apoptosis of
OPCs, enhancedOPCmaturation, and promotedmyelination in
a rabbit model of IVH. To our knowledge, this is the first dem-
onstration that AMPA-kainate inhibition protects OPCs and
improves myelination in an animal model of IVH. However, a
number of studies have examined the neuroprotective role
of AMPA-kainate antagonists in animal models of neonatal
hypoxia-ischemia, perinatal inflammation, and multiple sclero-
sis (Fern and Mo¨ller, 2000; Follett et al., 2000, 2004; Deng et al.,
2003; Kanwar et al., 2004). Consistent with our study, treatment
with NBQX and the anticonvulsant topiramate reduces oligo-
dendrocyte death and enhances myelination in rodent model of
Figure 6. NBQX treatment does not alter GFAP expression. A, Representative immunofluorescence of GFAP in the cryosections from D14 pups, as indicated. Abundant hypertrophic astrocytes
were observed in vehicle- and NBQX-treated pups with IVH. Scale bar, 50m. Inset, High-power view of astrocytes. Data are mean SEM (n 5 each). NBQX treatment did not affect volume
fractionof astroglial fibers comparedwithvehicle controls on stereological analysesonD14.B,Westernblot analyses forGFAPwereperformed in forebrainhomogenatesof pupsatD3.Adult rat brain
was positive control. Data are mean SEM (n 5 each). Values were normalized to-actin. IVH increased GFAP levels, and NBQX treatment did not affect GFAP expression in pups with IVH. C,
Westernblot analyses forGFAPwereperformed in forebrainhomogenatesof pups (D14). Adult rat brainwaspositive control. DataaremeanSEM(n5each). Valueswerenormalized to-actin.
IVH increased GFAP levels, and NBQX treatment did not affect GFAP expression in pups with IVH. *p 0.05, no IVH versus IVH. **p 0.01, no IVH versus IVH. ***p 0.001, no IVH versus IVH.
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neonatal hypoxia-ischemia (Follett et al., 2004). NBQX improves
survival of OPCs and remyelination as well as reduces axonal
damage resulting in amelioration of disease process in animals
models of multiple sclerosis (Groom et al., 2003; Kanwar et al.,
2004). However, systemic NBQX treatment has failed to reduce
apoptosis of OPCs in a neonatal model of the IL-6-induced
white matter injury (Cai et al., 2004). The role of AMPA-kainate
receptors has also been previously evaluated in oligodendrocyte
culture experiments. PrimaryOPC cultures under the conditions
of oxygen-glucose deprivation have shown activation of Ca2-
permeable AMPA receptors and NBQX treatment has offered
cytoprotection, suggesting AMPA-kainate receptors to be a ma-
jor mechanism of OPC injury (Follett et al., 2000; Tekko¨k and
Goldberg, 2001; Deng et al., 2003). Among cells of oligodendro-
cyte lineage, mature oligodendrocytes are less vulnerable to in-
jury compared with immature OPCs and preoligodendrocytes
(Fern and Mo¨ller, 2000; Follett et al., 2000). Together, AMPA-
kainate inhibition might offer an important strategy of neuro-
protection in premature infants with IVH.
Although we observed neuroprotection with NBQX treat-
ment, this agent exhibits renal toxicity and is not in clinical use.
Therefore, we tested perampanel, an FDA-approved antiepileptic
drug, in our model, which showed similar effects in enhancing
myelination and neurological recovery as NBQX treatment. Per-
ampanel is a potent, noncompetitive, and selective AMPA recep-
tor antagonist and a broad-spectrum anticonvulsant (Hanada et
al., 2011). It has low side-effect profile and lacks psychomimetic
properties because it does not interact with NMDA receptors
(Rogawski, 2011). Moreover, it has an attractive pharmacoki-
netic profile. For example, it has a long half-life, allowing once-
daily dosing, and interaction to other antiepileptic drugs is
limited to oxycarbazepine (Hanada et al., 2014). Dizziness and
somnolence are the common adverse effects in adult patients.
Perampanel has shown efficacy and safety in Phase III clinical
trials for partial seizures in a dose of 8 and 12 mg (Gidal et al.,
2015; Vazquez et al., 2015). In the present study, we treated rab-
bits with perampanel at 18–20 h after the induction of IVH.
Because 90% of all IVH occur within 72 h of birth and as preterm
infants in neonatal units undergo screening head ultrasound to
detect IVH during this period, it is feasible to initiate perampanel
treatment on these infants shortly after the development of IVH.
Figure 7. NBQX blocks p-STAT3 signaling. A, Representative Western blot analysis for total STAT3, pSTAT3 (Tyr), and pSTAT3 (Ser) levels in the brain homogenates from preterm rabbits as
indicated. Adult rat brainwas positive control. Valueswere normalized to-actin. Data aremean SEM (n 5 each). Total STAT-3 and pSTAT(Tyr) levels were significantly increased in pupswith
IVH compared with pups without IVH, which were significantly reduced by NBQX treatment. However, pSTAT3 (Ser) expression was comparable between groups. B, Representative immunofluo-
rescence of cryosections from 3-d-old E29 pup double-labeled with p-STAT-3 and Olig2-, GFAP-, or Sox2-specific antibodies. p-STAT-3 was expressed more abundantly in IVH pups compared with
controlswithout IVH. Also, Sox2, Olig-2, GFAP, and S100 cells (arrowhead) coexpress p-STAT3 in the periventricularwhitematter. Inset, High-power viewof the boxed area in the image.
Scale bar, 20 m. C, Representative Western blot analysis for nuclear factor 1 A (NFIA), Sox9, and NICD expression in the brain homogenates from preterm rabbits, as indicated. Values were
normalized to-actin. Data are mean SEM (n 5 each). NFIA, Sox9, and NICD levels were comparable between groups, as indicated.
3374 • J. Neurosci., March 16, 2016 • 36(11):3363–3377 Dohare et al. • AMPA-Kainate Receptor Inhibition and IVH
Together, our findings justify consideration of perampanel treat-
ment in preterm infants with IVH.
We demonstrated that AMPA-kainate blockade suppressed in-
flammation. Specifically, we noted that NBQX treatment reduced
apoptoticOPCdeath,microglia infiltration, and production of pro-
inflammatory cytokines, including TNF, IL1, LIF, and IL-6. It
appears that NBQX treatment reduced cell death by attenuating
Ca2 levels in the OPCs and consequently diminished microglia
infiltration in the white matter of rabbits with IVH. Importantly,
microglia express GluR2–5, GluR7, KA1, and KA2 receptors; and
activation of their Glu receptors triggers release of TNF- (Noda et
al., 2000; Hagino et al., 2004). Other proinflammatory cytokines
(IL-1 and interferon-) are also produced primarily by microglia
or T-lymphocytes in conditions of brain injury. LIF is an IL-6 class
cytokine that inhibits cell differentiation. Hence, we speculate that
downregulation of LIF, TNF, and IL1 with NBQX treatment
might have promoted maturation of OPCs in rabbits with IVH
(Falahati et al., 2013; Rittchen et al., 2015). Because AMPA inhibi-
tionalsoblocksTNF- andIL1-inducedoligodendrocyteandneu-
ronal death (Hermann et al., 2001; Takahashi et al., 2003),
downregulationof cytokines byNBQXtreatment in our rabbit pups
might have reduced apoptosis of OPC after IVH. NBQX has been
shownto induceprotectivehypothermia (NurseandCorbett, 1996).
However, we observed no difference in the rectal temperature be-
tween NBQX-treated and vehicle controls, which is consistent with
the other studies (Hagberg et al., 1994; Follett et al., 2000). Thus,
activation of AMPA receptors contributed to apoptotic cell death,
microglial infiltration, and release of cytokines; and NBQX treat-
ment seemingly ameliorated inflammation, reduced release of
TNF and IL-1 from microglia, and consequently enhanced sur-
vival andmaturation of OPCs.
Composition of AMPA receptors, particularly the expression of
GluR2 subunit, has a critical impact on AMPA-mediated toxicity,
and the relative expressionof theAMPAsubunits alters duringbrain
Figure 8. Perampanel treatment restores myelination in rabbits with IVH. A, Representative immunofluorescence of MBP in the corona radiata of D14 pups. Data aremean SEM (n 5 each
group). Volume fractions ofMBPwere higher in the corpus callosumand corona radiata of perampanel-treated pups comparedwith vehicle controlswith IVH. Scale bar, 200m.V, Ventricular side.
B, Typical Western blot analysis for MBP expression in the forebrain of premature rabbit pups, as indicated, at D14. Adult rat brain was used as positive control. Each lane represents one brain. Bar
chart represents mean SEM (n 5 each group). MBP abundance was higher in perampanel-treated pups compared with vehicle controls. C, Western blot analysis of MAG expression in the
forebrainof pups as indicatedatD14.Bar graph representsmeanSEM(n5eachgroup).MAGexpressionwashigher inperampanel-treatedpups comparedwith vehicle controls. ***p0.001,
pups with versus without IVH. #p 0.05, vehicle versus parempanel-treated pups with IVH. ###p 0.001, vehicle versus parempanel-treated pups with IVH. D, Representative immunofluores-
cence of corona radiata from cryosections labeledwith GFAP antibody, as indicated. Note abundant hypertrophic astrocytes in vehicle- and NBQX-treated pupswith IVH. Scale bar, 50m. Data are
mean SEM (n 5 each). Perampanel treatment did not affect volume fraction of astroglial fibers compared with vehicle controls on stereological analyses. E, F, Western blot analyses for GFAP
and vimentin were performed in forebrain homogenates of pups (D14). Adult rat brain was positive control. Data aremean SEM (n 5 each). Values were normalized to-actin. Vimentin and
GFAP levels were elevated in pups with IVH comparedwith pups without IVH. Perampanel treatment did not affect GFAP or vimentin expression. *p 0.05, no IVH versus IVH. **p 0.01, no IVH
versus IVH. ***p 0.001, no IVH versus IVH.
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development and in brain pathologies (Pellegrini-Giampietro et al.,
1992). AMPA receptor composition has been evaluated in the em-
bryonic white matter of human fetuses and preterm infants of
18–46 gestational weeks (Talos et al., 2006a, b). GluR1 expression
remains above adult level and does not change significantly with
advance in gestational age. In contrast, GluR2 expression in the em-
bryonic brain is 40%-60% of the adult level and gradually in-
creases as gestational age advances. GluR3 and GluR4 levels are
several-fold higher in preterm infants and gradually drops to adult
level by the end of pregnancy. In the present study, we did not find
any difference in the expression ofGluR1-GluR4 in infantswith and
without IVH in our analyses of human samples. However, wemade
an important observation that GluR1 and GluR2 were significantly
reduced in periventricular white matter and germinal matrix com-
pared with the cortex. Because the presence of GluR2 subunit ren-
ders AMPA receptors impermeable toCa2, diminished expression
of GluR2 in white matter and germinal matrix can increase their
vulnerability to Ca2-induced injury, unlike the cortical mantle.
Conversely, a reduction inGluR1expressionwill decreaseCa2per-
meability and diminish glutamate-induced excitotoxicity. Thus, the
ratio of GluR1 and GluR2 expression in IVH is likely to determine
the Ca2 permeability and subsequent neurotoxicity.
JAK-STAT3 pathways regulate cell survival, proliferation, and
differentiation (Aaronson andHorvath, 2002). They are active dur-
ing periods of neuronal and glial differentiation and are stimulated
bycytokines (Cattaneoetal., 1999).STAT3 is expressedbyastrocytes
andOPCs and plays a key role inmediating astrogliosis inmodels of
spinal cord injury, traumatic brain damage, and cerebral infection
(Na et al., 2007; Herrmann et al., 2008; Zhao et al., 2011). Accord-
ingly, we found increased phosphorylation (tyrosine 705) and ele-
vated total levels of STAT-3 in pups with IVH and restoration after
NBQX treatment. However, NBQX treatment did not affect prolif-
eration of astrocytes, GFAP expression, or the levels of transcription
factors regulating astrocytes (NFIAandSOX9) inourmodel of IVH.
Previous study in a paradigm of neuropathic pain has shown that
JAK-STAT3 activation increases astrocyte proliferation. STAT-3
knock out animals also exhibit reduced GFAP expression in several
models of brain injury (O’Callaghan et al., 2014). Coculture studies
of neural stem cells and microglia have demonstrated that STAT-3
activation increases astrogliosis via Notch and Sox9 signaling path-
way (Zhu et al., 2008). Together, AMPA blockade did not affect
astrogliosis despite inhibition of STAT-3 signaling, which indicates
that other signaling pathways (Notch, bonemorphogenetic protein,
or transforminggrowth factor)mightalsobecontributing to IVH-
induced astrogliosis.
In conclusion, this study discovered previously an unknown role
of AMPA-kainate receptors in IVH-induced hypomyelination and
identified a novel strategy to restore myelination in the survivors of
IVH. Reduced GluR2 expression in the OPCs of the white matter
and germinal matrix likely contributed to their high propensity to
IVH-induced injury. More importantly, AMPA-kainate inhibition
byNBQXtreatment suppressed inflammation, reducedapoptosis of
OPCs, enhanced their maturation and myelination, and promoted
neurologic recovery.AMPAreceptor-specific inhibitor perampanel,
anFDA-approveddrug,was also found to restoremyelinationof the
white matter and neurological function; therefore, perampanel
treatment might improve the neurological outcome of preterm in-
fants with IVH.
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